Spectinomycin
General information:
| Withdrawn ID: | 1001 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | J01XX04 |
| Molecular Formula: | C14H24N2O7 |
| Molweight: | 332.35 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1971 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Spectinomycin as primary suspect: | 1 |
|---|
Reported final outcomes:
Reported side-effects:
| Side-effect | Case number |
|---|---|
| Neurogenic shock | 1 |
| Injection site pain | 1 |
| Feeling abnormal | 1 |
Toxicity information:
| Toxicity class: | 2 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 50 mg/kg |
External links:
| ChEBML: | CHEMBL1167 |
|---|---|
| DrugBank: | DB00919 |